Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
UMP Healthcare Holdings Ltd
0722UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in Hong Kong, Macau, and Mainland China. It operates in three segments, Hong Kong & Macau Corporate Healthcare Solution Services, Hong Kong & Macau Clinical Healthcare Services, and Mainland China Clinical Healthcare Services. The company offers general practice and family medicine; specialist consultation services, including internal medicine, surgery, pediatrics, cardiology, dermatology, otorhinolaryngology, orthopedics, ophthalmology, urology, gastroenterology and hepatology, radiology, endocrinology, and diabetes; and dental care services, such as dental implant, cosmetic dentistry, periodontal treatments, and orthodontics, as well as traditional Chinese medicines. It also provides physiotherapy services comprising muscle-strengthening, limb function, eye-hand coordination, and hand function trainings; day surgery and endoscopy; diagnostic imaging and laboratory; preventive medicines and health assessment; visa medical examination; vaccination and consultation; vision care and optometry; plastic, head, and neck surgeries; medical and cosmetics dermatology, and aesthetics; chronic disease management, such as hypertension, cardiovascular disease, diabetes, and joint diseases; and corporate healthcare solutions and third party administration services. In addition, the company offers WeWell Healthcare, a health service platform for family health management, recommending, and arranging professional medical and health services for each family member, including health checkup, vaccinations, and other specialist medical services referrals, etc. Further, it provides specialist consultation services. It serves insurance companies and corporations, and self-paid patients. The company was founded in 1990 and is headquartered in Central, Hong Kong. Address: Wing On House, Central, Hong Kong
Analytics
Zielpreis von Wall Street
18.76 HKDKGV
8.6Dividendenrendite
7.67 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 0722
Dividenden-Analyse 0722
Dividendenwachstum über 5 Jahre
62 %Kontinuierliches Wachstum
7 JahreAusschüttungsquote 5-Jahres-Durchschnitt
86 %Verlauf der Dividende 0722
Bewertung der Aktie 0722
Finanzen 0722
Ergebnisse | 2019 | Dynamik |